Vinati Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:37 pm

Quick Insight

Vinati Organics Ltd, a key player in the organic chemicals industry with a share price of 1,714 and a market cap of 17,766 Cr., exhibits strong financial performance indicators. With a P/E ratio of 40.2, ROE of 15.8%, and ROCE of 20.6%, the company demonstrates efficient utilization of capital and solid profitability. Operating at a 31% margin, Vinati Organics has a net profit of 415 Cr. and reserves amounting to 2,796 Cr. The company's low borrowings of ₹63 Cr. coupled with a comfortable ICR of 1202.37x indicate a healthy financial position. With a high P/BV of 5.86x and a CCC of 119 days, Vinati Organics presents an attractive investment opportunity in the chemicals sector, supported by robust fundamentals and prudent financial management.

Competitors of Vinati Organics Ltd

All Competitor Stocks of Vinati Organics Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:25 am

Below is a detailed analysis of the quarterly data for Vinati Organics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 542.00 Cr.. The value appears to be declining and may need further review. It has decreased from 648.00 Cr. (Mar 2025) to 542.00 Cr., marking a decrease of 106.00 Cr..
• For Expenses, as of Jun 2025, the value is 376.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 465.00 Cr. (Mar 2025) to 376.00 Cr., marking a decrease of 89.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 166.00 Cr.. The value appears to be declining and may need further review. It has decreased from 184.00 Cr. (Mar 2025) to 166.00 Cr., marking a decrease of 18.00 Cr..
• For OPM %, as of Jun 2025, the value is 31.00%. The value appears strong and on an upward trend. It has increased from 28.00% (Mar 2025) to 31.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 21.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 151.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 151.00 Cr., marking a decrease of 18.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 113.00 Cr.. The value appears to be declining and may need further review. It has decreased from 128.00 Cr. (Mar 2025) to 113.00 Cr., marking a decrease of 15.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.88. The value appears to be declining and may need further review. It has decreased from 12.31 (Mar 2025) to 10.88, marking a decrease of 1.43.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:29 pm

Growth

Last Updated: September 5, 2025, 1:51 pm

Balance Sheet

Last Updated: July 25, 2025, 2:06 pm

Below is a detailed analysis of the balance sheet data for Vinati Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,796.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,454.00 Cr. (Mar 2024) to 2,796.00 Cr., marking an increase of 342.00 Cr..
• For Borrowings, as of Mar 2025, the value is 63.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5.00 Cr. (Mar 2024) to 63.00 Cr., marking an increase of 58.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 394.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 358.00 Cr. (Mar 2024) to 394.00 Cr., marking an increase of 36.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,263.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,827.00 Cr. (Mar 2024) to 3,263.00 Cr., marking an increase of 436.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,382.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,330.00 Cr. (Mar 2024) to 1,382.00 Cr., marking an increase of 52.00 Cr..
• For CWIP, as of Mar 2025, the value is 298.00 Cr.. The value appears strong and on an upward trend. It has increased from 246.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 52.00 Cr..
• For Investments, as of Mar 2025, the value is 523.00 Cr.. The value appears strong and on an upward trend. It has increased from 237.00 Cr. (Mar 2024) to 523.00 Cr., marking an increase of 286.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,059.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,014.00 Cr. (Mar 2024) to 1,059.00 Cr., marking an increase of 45.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,263.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,827.00 Cr. (Mar 2024) to 3,263.00 Cr., marking an increase of 436.00 Cr..

Notably, the Reserves (2,796.00 Cr.) exceed the Borrowings (63.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Vinati Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 39.09. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.09, marking an increase of 7.94.
• For Diluted EPS (Rs.), as of Mar 25, the value is 39.09. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.09, marking an increase of 7.94.
• For Cash EPS (Rs.), as of Mar 25, the value is 47.62. This value is within the healthy range. It has increased from 38.19 (Mar 24) to 47.62, marking an increase of 9.43.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.36. It has increased from 221.98 (Mar 24) to 269.36, marking an increase of 47.38.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.36. It has increased from 221.98 (Mar 24) to 269.36, marking an increase of 47.38.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 216.80. It has increased from 183.28 (Mar 24) to 216.80, marking an increase of 33.52.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 60.29. This value is within the healthy range. It has increased from 49.05 (Mar 24) to 60.29, marking an increase of 11.24.
• For PBIT / Share (Rs.), as of Mar 25, the value is 51.76. This value is within the healthy range. It has increased from 42.02 (Mar 24) to 51.76, marking an increase of 9.74.
• For PBT / Share (Rs.), as of Mar 25, the value is 51.70. This value is within the healthy range. It has increased from 41.67 (Mar 24) to 51.70, marking an increase of 10.03.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 39.08. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.08, marking an increase of 7.93.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 39.08. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.08, marking an increase of 7.93.
• For PBDIT Margin (%), as of Mar 25, the value is 27.81. This value is within the healthy range. It has increased from 26.76 (Mar 24) to 27.81, marking an increase of 1.05.
• For PBIT Margin (%), as of Mar 25, the value is 23.87. This value exceeds the healthy maximum of 20. It has increased from 22.92 (Mar 24) to 23.87, marking an increase of 0.95.
• For PBT Margin (%), as of Mar 25, the value is 23.84. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 23.84, marking an increase of 1.11.
• For Net Profit Margin (%), as of Mar 25, the value is 18.02. This value exceeds the healthy maximum of 10. It has increased from 16.99 (Mar 24) to 18.02, marking an increase of 1.03.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.02. This value is within the healthy range. It has increased from 16.99 (Mar 24) to 18.02, marking an increase of 1.03.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.50. This value is below the healthy minimum of 15. It has increased from 14.03 (Mar 24) to 14.50, marking an increase of 0.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.09. This value is within the healthy range. It has increased from 16.61 (Mar 24) to 18.09, marking an increase of 1.48.
• For Return On Assets (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has increased from 11.37 (Mar 24) to 12.35, marking an increase of 0.98.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has increased from 0.70 (Mar 24) to 0.73, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 4.53 (Mar 24) to 3.31, marking a decrease of 1.22.
• For Quick Ratio (X), as of Mar 25, the value is 2.61. This value exceeds the healthy maximum of 2. It has decreased from 3.62 (Mar 24) to 2.61, marking a decrease of 1.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.63. This value is within the healthy range. It has increased from 5.19 (Mar 24) to 5.63, marking an increase of 0.44.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 22.27 (Mar 24) to 0.00, marking a decrease of 22.27.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 18.17 (Mar 24) to 0.00, marking a decrease of 18.17.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 77.73 (Mar 24) to 0.00, marking a decrease of 77.73.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 81.83 (Mar 24) to 0.00, marking a decrease of 81.83.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1,202.37. This value is within the healthy range. It has increased from 140.04 (Mar 24) to 1,202.37, marking an increase of 1,062.33.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 780.33. This value is within the healthy range. It has increased from 89.94 (Mar 24) to 780.33, marking an increase of 690.39.
• For Enterprise Value (Cr.), as of Mar 25, the value is 16,441.23. It has increased from 15,241.12 (Mar 24) to 16,441.23, marking an increase of 1,200.11.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.31. This value exceeds the healthy maximum of 3. It has decreased from 8.02 (Mar 24) to 7.31, marking a decrease of 0.71.
• For EV / EBITDA (X), as of Mar 25, the value is 26.30. This value exceeds the healthy maximum of 15. It has decreased from 29.97 (Mar 24) to 26.30, marking a decrease of 3.67.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 8.03 (Mar 24) to 7.29, marking a decrease of 0.74.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 77.72 (Mar 24) to 0.00, marking a decrease of 77.72.
• For Price / BV (X), as of Mar 25, the value is 5.86. This value exceeds the healthy maximum of 3. It has decreased from 6.63 (Mar 24) to 5.86, marking a decrease of 0.77.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 8.03 (Mar 24) to 7.29, marking a decrease of 0.74.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness